---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-026154"
form_type: "8-K"
ticker: "BBWI"
cik: "0000701985"
company_name: "Bath & Body Works, Inc."
filed_at: "2022-02-23T23:59:59+00:00"
generated_at: "2026-06-27T05:42:13.851853+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BBWI reports record Q4/FY21 earnings, CEO Meslow to step down in May due to health

## Summary
- Q4 net sales $3.027B (+11% YoY); GAAP EPS $2.27, adjusted EPS $2.30 (+17% YoY).
- FY21 net sales $7.882B (+22%); adjusted EPS $4.51 (+45% YoY). Q1/FY22 guidance below prior year adjusted.
- Board authorized $1.5B share repurchase program and 33% increase to annual dividend.
- CEO Andrew Meslow steps down May 12, 2022 for health reasons; Board Chair Sarah Nash becomes Executive Chair and Interim CEO.
- Board plans to retain a national search firm to identify permanent CEO.

## SEC filing metadata
- accession: 0001104659-22-026154
- form_type: 8-K
- ticker: BBWI
- cik: 0000701985
- company_name: Bath & Body Works, Inc.
- filed_at: 2022-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/tm227471d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-026154
- JSON: https://secwatch.observer/filing/0001104659-22-026154.json
- Plain text: https://secwatch.observer/filing/0001104659-22-026154.txt

## Key facts
- Executive change
  Sarah E. Nash was appointed as Interim Chief Executive Officer at Bath & Body Works, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm
- Executive change
  Sarah E. Nash was appointed as Executive Chair at Bath & Body Works, Inc..
  - Action: appointed
  - Role: Executive Chair
  source text: On February 22, 2022, the Board of Directors (the “Board”) of the Company appointed current Board Chair Sarah E. Nash as Executive Chair, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm
- Executive change
  Andrew M. Meslow departed as Chief Executive Officer at Bath & Body Works, Inc..
  - Action: step down
  - Role: Chief Executive Officer
  source text: Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.